Kura Oncology (KURA) director receives 35,000 options at $8.77 strike price
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Kura Oncology director Helen Louise Collins received a new stock option grant that increases her potential equity stake in the company. She was awarded options to purchase 35,000 shares of common stock at an exercise price of $8.77 per share. The options vest in full on the one-year anniversary of the grant date and expire on June 3, 2036. Following this grant, she holds options covering 35,000 shares directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Collins Helen Louise
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Option to purchase common stock | 35,000 | $0.00 | -- |
Holdings After Transaction:
Option to purchase common stock — 35,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 35,000 options
Exercise price: $8.77 per share
Expiration date: June 3, 2036
+2 more
5 metrics
Option grant size
35,000 options
Options to purchase common stock granted to director
Exercise price
$8.77 per share
Strike price for newly granted options
Expiration date
June 3, 2036
Option grant expiration
Underlying shares
35,000 shares
Common stock underlying the options
Post-grant option holdings
35,000 options
Total derivative shares following transaction
Key Terms
Option to purchase common stock, grant/award acquisition, exercise price, expiration date, +1 more
5 terms
Option to purchase common stock financial
"security_title: Option to purchase common stock"
grant/award acquisition financial
"transaction_action: grant/award acquisition"
exercise price financial
"conversion_or_exercise_price: 8.7700"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-03T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vests in full financial
"This option vests in full on the one year anniversary"
FAQ
What insider transaction did Kura Oncology (KURA) report for Helen Louise Collins?
Kura Oncology reported that director Helen Louise Collins received options to purchase 35,000 shares of common stock. The grant was recorded as a compensation-related award, not an open-market purchase or sale of existing shares.
What is the exercise price of the new Kura Oncology (KURA) stock options?
The newly granted options to Helen Louise Collins have an exercise price of $8.77 per share. This is the price she must pay per share to convert the options into common stock once they are vested and exercised.
When do Helen Louise Collins’s Kura Oncology (KURA) options vest?
The options granted to Helen Louise Collins vest in full on the one-year anniversary of the grant date. She must wait until that vesting date before exercising the options to acquire Kura Oncology common shares.
When do the newly granted Kura Oncology (KURA) options expire?
The stock options granted to Helen Louise Collins expire on June 3, 2036. If not exercised by that expiration date, the options will lapse and no longer allow her to purchase Kura Oncology common stock.